Ardsley Advisory Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-22,100
Closed -$185K 202
2015
Q1
$185K Buy
22,100
+2,100
+11% +$16.5K 0.03% 171
2014
Q4
$153K Buy
20,000
+10,000
+100% +$71.6K 0.02% 174
2014
Q3
$69K Sell
10,000
-10,000
-50% -$74.7K 0.01% 179
2014
Q2
$165K Hold
20,000
0.02% 227
2014
Q1
$161K Hold
20,000
0.02% 214
2013
Q4
$160K Buy
+20,000
New +$155K 0.02% 150

Other funds holding LMAT

Ardsley Advisory Partners's LMAT Position: Q2 2015 in Review

Ardsley Advisory Partners sold out of LeMaitre Vascular (LMAT) in Q2 2015, closing a stake of 22,100 shares — an estimated $185K sold.

Ardsley Advisory Partners first reported a position in LMAT in Q4 2013 and held it in 6 quarters. The position peaked at $185K in Q1 2015. 75 funds tracked by Wall St. Rank hold LMAT as of Q2 2015.

  • Ardsley Advisory Partners reported no remaining LeMaitre Vascular position as of Q2 2015 after selling out during the quarter.
  • Ardsley Advisory Partners sold 22,100 LeMaitre Vascular shares in Q2 2015, an estimated $185K.
  • Ardsley Advisory Partners first reported a position in LeMaitre Vascular in Q4 2013 and held it in 6 quarters.
  • Ardsley Advisory Partners's LeMaitre Vascular position peaked at $185K in Q1 2015.
  • 75 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2015.

Based on Ardsley Advisory Partners's 13F filing for Q2 2015, filed 14 Aug 2015.